IRCT2016121213090N3招募中3 期
Investigating the effects of rosuvastatin in the acute cardiomyopathy induced anthracycline in cancer patients under chemotherapy
Vice chancellor for research of Mazandaran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Cancerous patients undergoing treatment with anthracycline
- •Exclusion criteria: Patients with history of myocardial infarction; coronary artery disease; patients in the early stages of chemotherapy or radiotherapy; acute restraint or dilated cardiomyopathy; mitral and aortic valvular diseases in initial echocardiography; patients with a history or any symptoms associated with heart failure; hypersensivity to rosuvastatin; active liver diseases; and impaired liver tests; pregnant and lactating women.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Evaluation of the effects of Rosuvastatin in the treatment of patients with deep vein thrombosis(DVT)IRCT20150621022852N4Shahid Beheshti University of Medical Sciences50
招募中
2 期
Rosuvastatin in patients with moderate brain traumaModerate traumatic brain injury.Diffuse traumatic brain injuryS06.2IRCT20230627058603N2Esfahan University of Medical Sciences200
已完成
3 期
The assessment of effect of Rosuvastatin use in venous thromboembolismVenous thromboembolism includes deep vein thrombosis and pulmonary embolism.venous embolism and thrombosisCode I82IRCT20210416050990N1Shahid Beheshti University of Medical Sciences220
招募中
不适用
Evaluation of the effect of rosuvastatin on renoprotective effectType 2 diabetesJPRN-UMIN000021583Rosuvastatin-kidney study group40
已完成
不适用
A study to evaluate the efficacy of Rosuvastatin for patients with coronary plaque utilizing aggressive lipid lowering treatmentHypercholesterolemiaJPRN-UMIN000001223Kokura Memorial Hospital400